Fortis Healthcare (NSE:FORTIS) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:FORTIS Fortis Healthcare Ltd NSE:FORTIS
81 GF Score
Price ₹945.15
GF Value ₹847.82
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Fortis Healthcare Marketable Securities?

Fortis Healthcare NSE:FORTIS -1.05% 81 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:FORTIS with a GF Score™ of 81/100 and a GF Value™ of ₹847.82 (Modestly Overvalued). The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Fortis Healthcare's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Fortis Healthcare's annual Marketable Securities increased from Mar. 2024 (₹3,650 Mil) to Mar. 2025 (₹3,660 Mil) but then declined from Mar. 2025 (₹3,660 Mil) to Mar. 2026 (₹1,517 Mil).

Fortis Healthcare  (NSE:FORTIS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Fortis Healthcare Marketable Securities Related Terms

Fortis Healthcare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Fortis Healthcare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortis Healthcare Marketable Securities Chart

Fortis Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,693.32 2,252.09 3,650.28 3,659.83 1,517.00

Fortis Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3,470.90 0.00 1,517.00 0.00
NSE:FORTIS
81GF Score
Fortis Healthcare Ltd NSE:FORTIS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortis Healthcare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Fortis Healthcare (NSE:FORTIS) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Fortis Healthcare and its competitors.
Is Fortis Healthcare's Marketable Securities too high?
Fortis Healthcare's current Marketable Securities is ₹0 Mil. Overall, Fortis Healthcare has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortis Healthcare's Marketable Securities compare to HCA and THC?
Fortis Healthcare's Marketable Securities of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Fortis Healthcare and its competitors. Fortis Healthcare's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fortis Healthcare (NSE:FORTIS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹847.82, compared to a current price of ₹945.15 — trading 11.5% above its estimated fair value. The current Marketable Securities is ₹0 Mil. Fortis Healthcare's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Fortis Healthcare (NSE:FORTIS), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortis Healthcare (NSE:FORTIS) Overvalued in 2026?

Based on GuruFocus' analysis, Fortis Healthcare stock appears to be overvalued. The current stock price of ₹945.15 is trading 11.5% above its estimated GF Value™ of ₹847.82. GuruFocus considers Fortis Healthcare to be Modestly Overvalued.

Key valuation signals for NSE:FORTIS:

  • Marketable Securities: ₹0 Mil
  • GF Value™: ₹847.82 vs. price of ₹945.15 (11.5% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the NSE:FORTIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortis Healthcare Business Description

Other Exchanges 532843:India
Address Block - F, South City 1, Sector - 41, Tower-A, Unitech Business Park, Gurgaon, HR, IND, 122001
Fortis Healthcare Ltd provides integrated healthcare delivery services in India. The company manages healthcare centers including hospitals, diagnostics, and day care specialty facilities. The company's key specialty in its hospital business is cardiac sciences. It is predominantly engaged in the business of healthcare services which is the only reportable segment. The company's key hospitals include Fortis Escorts Heart Institute in Dehli, Fortis Mulund in Mumbai, and Fortis Hospital in Bengaluru. The majority of the company's revenue is derived from India.
81GF Score

Get the complete analysis for NSE:FORTIS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹945.15
Price
₹847.82
GF Value